Ting Han, Hui Zhang, Wenjuan Xu, Chunshuai Li, Min Wang, Yuying Bai, Linlin Yang, Shuyan Zhang, Zhe Jia, Xinfang Xu, Chongjun Zhao, Feng Wei, Xiangri Li
Background: Realgar was usually selected as a substitute for arsenic trioxide to treat acute promyelocytic leukemia due to its higher effect without high cardiotoxicity. In traditional Chinese medicine (TCM), realgar is usually processed by the water-grinding method clinically, but the mechanism of realgar processing detoxification is still unclear. However, it is necessary to take safety and efficacy into account while evaluating a drug. Methods: Sixty male Wistar rats were divided into control group, realgar products-treated groups, and corresponding subgroups...
2021: Evidence-based Complementary and Alternative Medicine: ECAM